Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | | | | 245 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 245 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 85 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | APPL1 CL E G H | 26060 | 24035 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 2 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | BLK CL E G H | 640 | 1057 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 75 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 105 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 11 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 48 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | CEL CL E G H | 1056 | 1848 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 25 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | CIDEC CL E G H | 63924 | 24229 | OMIM:615238 | Lipodystrophy, familial partial, type 5 | | | | 8 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | CNOT1 CL E G H | 23019 | 7877 | ORPHA:556955 | Pancreatic agenesis-holoprosencephaly syndrome | | | | 2 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | | | | | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | GCK CL E G H | 2645 | 4195 | OMIM:606176 | DIABETES MELLITUS, PERMANENT NEONATAL; PNDM | | | | 237 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | GCK CL E G H | 2645 | 4195 | ORPHA:79299 | Hyperinsulinism due to glucokinase deficiency | HP:0040281 - Very frequent | | | 237 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | GCK CL E G H | 2645 | 4195 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 237 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | | | | 161 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | HNF1A CL E G H | 6927 | 11621 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 161 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | HNF4A CL E G H | 3172 | 5024 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 138 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | INS CL E G H | 3630 | 6081 | OMIM:618858 | DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4 | | | | 62 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | INS CL E G H | 3630 | 6081 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 62 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:263458 | Hyperinsulinism due to INSR deficiency | HP:0040281 - Very frequent | | | 229 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:769 | Rabson-Mendenhall syndrome | | | | 229 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79644 | Autosomal recessive hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | KCNJ11 CL E G H | 3767 | 6257 | OMIM:618856 | DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2 | | | | 127 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 127 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | KLF11 CL E G H | 8462 | 11811 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 78 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | NAB2 CL E G H | 4665 | 7627 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | | | | | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | NEUROD1 CL E G H | 4760 | 7762 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 32 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | PAX4 CL E G H | 5078 | 8618 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 55 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | PDX1 CL E G H | 3651 | 6107 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 30 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | PDX1 CL E G H | 3651 | 6107 | OMIM:260370 | Pancreatic agenesis, congenital | | | | 30 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 42 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | STAT6 CL E G H | 6778 | 11368 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | | | | 1 | | |
HP:0030794 | HP:0030794 | Abnormal circulating C-peptide concentration | 0 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | | | | 15 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | HP:0040281 - Very frequent | | | 245 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 85 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 105 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 11 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 48 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | CIDEC CL E G H | 63924 | 24229 | OMIM:615238 | Lipodystrophy, familial partial, type 5 | | | | 8 | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | CNOT1 CL E G H | 23019 | 7877 | ORPHA:556955 | Pancreatic agenesis-holoprosencephaly syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | GCK CL E G H | 2645 | 4195 | OMIM:606176 | DIABETES MELLITUS, PERMANENT NEONATAL; PNDM | | | | 237 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040281 - Very frequent | | | 41 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | HP:0040281 - Very frequent | | | 161 | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | INS CL E G H | 3630 | 6081 | OMIM:618858 | DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4 | | | | 62 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | INSR CL E G H | 3643 | 6091 | ORPHA:769 | Rabson-Mendenhall syndrome | HP:0040282 - Frequent | | | 229 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | HP:0040281 - Very frequent | | | 127 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79644 | Autosomal recessive hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | KCNJ11 CL E G H | 3767 | 6257 | OMIM:618856 | DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2 | | | | 127 | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | NAB2 CL E G H | 4665 | 7627 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | HP:0040284 - Very rare | | | | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | PDX1 CL E G H | 3651 | 6107 | OMIM:260370 | Pancreatic agenesis, congenital | | | | 30 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0030794 | HP:0030795 | Reduced C-peptide level | 1 | STAT6 CL E G H | 6778 | 11368 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | HP:0040284 - Very rare | | | 1 | | |
HP:0030794 | HP:0030796 | Increased C-peptide level | 1 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | HP:0040281 - Very frequent | | | 15 | | |